Norpace
NDC 68151-0527
Product Information
Norpace is a NDA-approved product labeled by Carilion Materials Management. This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat, such as persistent ventricular tachycardia. It is supplied as a brown product. This product entry covers the primary NDC 68151-0527 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
GREEN (C48329 - LIGHT GREEN)
SEARLE;2742;NORPACE;CR;150;MG
Code Structure Chart
Product Details
What is NDC 68151-0527?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DISOPYRAMIDE PHOSPHATE (UNII: N6BOM1935W)
- DISOPYRAMIDE (UNII: GFO928U8MQ) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STARCH, CORN (UNII: O8232NY3SJ)
- ETHYLCELLULOSES (UNII: 7Z8S9VYZ4B)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- GELATIN (UNII: 2G86QN327L)
- SHELLAC (UNII: 46N107B71O)
- SUCROSE (UNII: C151H8M554)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FD&C RED NO. 3 (UNII: PN2ZH5LOQY)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 209692 - Norpace 150 MG Oral Capsule
- RxCUI: 209692 - disopyramide 150 MG Oral Capsule [Norpace]
- RxCUI: 209692 - Norpace (as disopyramide phosphate) 150 MG Oral Capsule
- RxCUI: 309960 - disopyramide phosphate 150 MG Oral Capsule
- RxCUI: 309960 - disopyramide 150 MG Oral Capsule
* Please review the full disclaimer at the bottom of this page.